1. Home
  2. GPK vs NVAX Comparison

GPK vs NVAX Comparison

Compare GPK & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

N/A

Current Price

$10.87

Market Cap

2.5B

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.52

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPK
NVAX
Founded
2007
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
GPK
NVAX
Price
$10.87
$8.52
Analyst Decision
Hold
Buy
Analyst Count
11
9
Target Price
$12.10
★ $14.11
AVG Volume (30 Days)
★ 8.1M
6.1M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 4.08%
N/A
EPS Growth
N/A
★ 309.76
EPS
★ 0.01
N/A
Revenue
★ $8,617,000,000.00
$1,123,479,000.00
Revenue This Year
$0.33
N/A
Revenue Next Year
$1.91
N/A
P/E Ratio
$1,079.50
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$8.15
$6.20
52 Week High
$16.61
$13.39

Technical Indicators

Market Signals
Indicator
GPK
NVAX
Relative Strength Index (RSI) 61.67 37.52
Support Level $10.09 $7.81
Resistance Level $11.31 $10.53
Average True Range (ATR) 0.46 0.76
MACD 0.13 -0.16
Stochastic Oscillator 67.39 5.98

Price Performance

Historical Comparison
GPK
NVAX

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: